Senior Leadership

高层领导

基本信息

批准号：
8461253
负责人：
RUSSEL E. KAUFMAN
金额：
$ 24.68万
依托单位：
WISTAR INSTITUTE
依托单位国家：
美国
项目类别：
财政年份：
资助国家：
美国
起止时间：
至 2014-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8461253
关键词：
Achievement Administrator Advisory Committees Advocacy Advocate Alveolar Rhabdomyosarcoma American American Association of Cancer Research American Cancer Society Antibodies Appointment Award BRAF gene Basal cell carcinoma Basic Cancer Research Basic Science Binding Binding Sites Biological Biological Markers Biology Breast Budgets CD7 gene Calendar Cancer Biology Cancer Center Cancer Research Project Cell Cycle Cell surface Cells Charge Chemotherapy-Oncologic Procedure Clinical Clinical Investigator Clinical Research Collaborations Colon Commit Committee Membership Communities Complex Cutaneous Melanoma DNA Binding Decision Making Department of Defense Development Diagnosis Disease Doctor of Philosophy Drug usage Effectiveness Embryo Ensure Environment Esophagus Etiology Extramural Activities FOXO1A gene Foundations Funding Gene Expression Regulation Genetic Grant Head Cancer Health Hematology Human Immunologist Immunology Institutes Internal Medicine Laboratories Large Intestine Carcinoma Leadership Legal patent Ligands Malignant Neoplasms Mentorship Modeling Molecular Molecular Biology Molecular Genetics Monoclonal Antibodies Morphogenesis Multi-Drug Resistance Neoplasm Metastasis Nephroblastoma Oncogene Proteins Oncogenic PAX3 gene Patient Selection Pediatric Neoplasm Peer Review Pennsylvania Pharmacology Pigments Positioning Attribute Principal Investigator Proto-Oncogene Proteins c-fos Publications Records Recruitment Activity Reporting Research Research Infrastructure Research Personnel Research Project Grants Resources Role Roswell Park Cancer Institute Scientific Advances and Accomplishments Scientist Signal Transduction Signaling Molecule Site Visit Skin Skin Cancer Societies Specialized Program of Research Excellence Squamous Cell Strategic Planning Structural Biologist Study Section T-Cell Lymphoma T-Lymphocyte and Natural Killer Cell TNFRSF5 gene The Wistar Institute Therapeutic Time Tissues Training Transcriptional Regulation Translational Research Trustees Tumor Biology Tumor Cell Line Tumor Suppressor Proteins United States National Institutes of Health Universities Vision WT1 gene Wages Work adult stem cell anticancer research base cancer research center director cancer therapy career cell growth regulation cell transformation experience follow-up infrastructure development innovation insight interest jun Oncogene meetings melanoma member multidisciplinary new technology oncology oncology program outcome forecast outreach program post-doctoral training professor programs receptor small molecule sound symposium tool tumor tumorigenesis

项目摘要

The Wistar Institute Cancer Center Director is Dr. Russel Kaufman. He is assisted by two Deputy Directors: Drs. Meenhard Herlyn and Frank J. Rauscher, III. Dr. Herlyn is the Deputy Director for Translational Research. In this newly created position, Dr. Herlyn will cultivate intra- and inter-programmatic translational collaborations within the Cancer Center, helping to ensure that the needs of the Cancer Center principal investigators are met. He also will share in the recruiting efforts for new members of the Cancer Center, and provide advice to the Director. Dr. Frank J. Rauscher III is the Deputy Director for Basic Research. He holds several important national positions that give him a perspective on the directions and opportunities in basic cancer research, enabling him to provide scientific guidance to the Cancer Center Director and take a leadership role with program leaders and Cancer Center members in basic research planning, recruitment, and development of infrastructure.

Wistar Institute癌症中心主任是Russel Kaufman博士。他得到了两位副董事的协助：博士。 Meenhard Herlyn和Frank J. Rauscher，III。 Herlyn博士是翻译副主任研究。在这个新创建的位置中，赫林博士将培养跨编程间翻译癌症中心内的合作，有助于确保癌症中心校长的需求结识了调查人员。他还将分享为癌症中心的新成员的招聘工作，以及向董事提供建议。 Frank J. Rauscher III博士是基础研究副主任。他拥有几个重要的民族使他对基本癌症研究的方向和机遇的看法他为癌症中心主任提供科学指导，并在计划中发挥领导作用基础研究计划，招聘和发展的领导者和癌症中心成员基础设施。